Document ID: 32021D0098
Language: ENG

<table><col/><col/><col/><col/><tbody><tr><td><p>29.1.2021&#160;&#160;&#160;</p></td><td><p>EN</p></td><td><p>Official Journal of the European Union</p></td><td><p>L 31/214</p></td></tr></tbody></table>
COMMISSION IMPLEMENTING DECISION (EU) 2021/98
of 28 January 2021
not approving esbiothrin as an existing active substance for use in biocidal products of product-type 18
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products ( 1 ) , and in particular the third subparagraph of Article 89(1) thereof,
Whereas:
<table><col/><col/><tbody><tr><td><p>(1)</p></td><td><p>Commission Delegated Regulation (EU) No 1062/2014&#160;<a>(<span>2</span>)</a> establishes a list of existing active substances to be evaluated for their possible approval for use in biocidal products. That lists includes esbiothrin (EC No: Not available; CAS No: 260359-57-7).</p></td></tr></tbody></table>
<table><col/><col/><tbody><tr><td><p>(2)</p></td><td><p>Esbiothrin has been evaluated for use in biocidal products of product-type 18, insecticides, acaricides and products to control other arthropods, as described in Annex V to Regulation (EU) No 528/2012.</p></td></tr></tbody></table>
<table><col/><col/><tbody><tr><td><p>(3)</p></td><td><p>Germany was designated as the rapporteur Member State and its evaluating competent authority submitted the assessment report together with its conclusions to the European Chemicals Agency (&#8216;the Agency&#8217;) on 11 January 2017.</p></td></tr></tbody></table>
<table><col/><col/><tbody><tr><td><p>(4)</p></td><td><p>In accordance with Article 7(2) of Delegated Regulation (EU) No 1062/2014, the Biocidal Products Committee adopted the opinion of the Agency on 16 June 2020&#160;<a>(<span>3</span>)</a>, having regard to the conclusions of the evaluating competent authority.</p></td></tr></tbody></table>
<table><col/><col/><tbody><tr><td><p>(5)</p></td><td><p>According to that opinion, biocidal products of product-type 18 containing esbiothrin may not be expected to meet the criteria laid down in Article 19(1)(b) of Regulation (EU) No 528/2012 as the human health risk assessment identified unacceptable risks.</p></td></tr></tbody></table>
<table><col/><col/><tbody><tr><td><p>(6)</p></td><td><p>Taking into account the opinion of the Agency, the Commission considers it not appropriate to approve esbiothrin for use in biocidal products of product-type 18.</p></td></tr></tbody></table>
<table><col/><col/><tbody><tr><td><p>(7)</p></td><td><p>The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Biocidal products,</p></td></tr></tbody></table>
HAS ADOPTED THIS DECISION:
Article 1
Esbiothrin (EC No: Not available; CAS No: 260359-57-7) is not approved as an active substance for use in biocidal products of product-type 18.
Article 2
This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
Done at Brussels, 28 January 2021.
For the Commission
The President
Ursula VON DER LEYEN
<note>
( 1 ) OJ L 167, 27.6.2012, p. 1 .
( 2 ) Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 294, 10.10.2014, p. 1 ).
( 3 ) Biocidal Products Committee Opinion on the application for approval of the active substance: Esbiothrin, Product type: 18, ECHA/BPC/260/2020, adopted on 16 June 2020.
</note>